Emilie Denicolaï

Ex vivo cultures of glioblastoma in three-dimensional hydrogel maintain the original tumor growth behavior and are suitable for preclinical drug and radiation sensitivity screening

Carine Jiguet Jiglaire, Nathalie Baeza-Kallee, Emilie Denicolaï et al. · Experimental Cell Research · 2013 · 69 citations

Medicine, Bioengineering, Oncology +17

Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway

Émeline Tabouret, Aurélie Tchoghandjian, Emilie Denicolaï et al. · Oncotarget · 2015 · 55 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Inhibitor of apoptosis protein expression in glioblastomas and their in vitro and in vivo targeting by SMAC mimetic GDC-0152

Aurélie Tchoghandjian, Aurélie Soubéran, Émeline Tabouret et al. · Cell Death and Disease · 2016 · 51 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth<i>in vivo</i>

Emilie Denicolaï, Nathalie Baeza-Kallee, Aurélie Tchoghandjian et al. · Oncotarget · 2014 · 49 citations · Full text

Medicine, Oncology, Pharmacology +16

Proscillaridin A exerts anti-tumor effects through GSK3β activation and alteration of microtubule dynamics in glioblastoma

Raphaël Bergès, Emilie Denicolaï, Aurélie Tchoghandjian et al. · Cell Death and Disease · 2018 · 37 citations · Full text

Medicine, Oncology, Pharmacology +13